Diprivan and Blood amylase increased - a phase IV clinical study of FDA data

Summary:

Blood amylase increased is reported as a side effect among people who take Diprivan (propofol), especially for people who are female, 30-39 old, have been taking the drug for < 1 month also take Lovenox, and have Sedation.

The phase IV clinical study analyzes which people have Blood amylase increased when taking Diprivan. It is created by eHealthMe based on reports of 6,477 people who have side effects when taking Diprivan from the FDA, and is updated regularly.

What is Diprivan?

Diprivan has active ingredients of propofol. eHealthMe is studying from 6,496 Diprivan users. Check the latest studies of Diprivan.

What is Blood amylase increased?

Blood amylase increased is found to be associated with 458 drugs and 839 conditions by eHealthMe. Check the latest studies of Blood amylase increased.

On Jul, 20, 2026

6,477 people reported to have side effects when taking Diprivan.
Among them, 23 people (0.36%) have Blood amylase increased.

Could Diprivan cause Blood amylase increased?

Among these 23 people:

How long have people been on Diprivan when they have Blood amylase increased? *

What is the gender of people who have Blood amylase increased when taking Diprivan? *

female: 60.87 %
male: 39.13 %

What is the age of people who have Blood amylase increased when taking Diprivan? *

What are other drugs people take besides Diprivan? *

What are other side effects people have besides Blood amylase increased? *

Aspartate Aminotransferase Increased: 11 people, 47.83%
Lipase Increased: 11 people, 47.83%
Alanine Aminotransferase Increased: 9 people, 39.13%
Pancreatitis (inflammation of pancreas): 6 people, 26.09%
Hepatitis (inflammation of the liver): 4 people, 17.39%
Chills (felling of cold): 3 people, 13.04%
Blood Bilirubin Increased: 3 people, 13.04%
Pancreatitis Acute (sudden inflammation of pancreas): 3 people, 13.04%
Gamma-Glutamyltransferase Increased: 3 people, 13.04%
Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down): 3 people, 13.04%

What are the existing conditions these people have? *

Sedation: 5 people, 21.74%
Anaesthesia: 3 people, 13.04%
Ventricular Tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart): 1 person, 4.35%
Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin): 1 person, 4.35%
Sepsis (a severe blood infection that can lead to organ failure and death): 1 person, 4.35%
Reflux Oesophagitis (an oesophageal mucosal injury that occurs of gastric contents into the oesophagus): 1 person, 4.35%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 1 person, 4.35%
High Blood Pressure: 1 person, 4.35%
General Anaesthesia: 1 person, 4.35%
Aneurysm (enlargement of an artery caused by a weakening of the artery wall): 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Diprivan and have Blood amylase increased?

- Check whether Blood amylase increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Diprivan:

Diprivan (6,496 reports)

Browse all side effects of Diprivan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Blood amylase increased:

Blood amylase increased (458 drugs)

Browse all the conditions that are associated with Blood amylase increased:

Blood amylase increased (839 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on propofol (the active ingredients of Diprivan) and Diprivan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.